Who is SurgMark?

We are a company specializing in innovative solutions in medical technology and biotechnology. Our team is interdisciplinary: the shareholders come from the fields of medicine, development and the start-up scene.
We have many years of industry experience, looking back on successful start-ups and product innovations. Our management team has executed several successful business exits in the form of trade sales for investors. 
In this way, we combine expertise with a keen eye for market potential.

Our Mission

SurgMark is committed to developing innovative solutions for the diagnosis and therapy of breast cancer and other tumor diseases. With our latest tool SchurSign we combine know-how from breast surgery and biomaterial research.

About us

Know-How in Medtec and Start ups: 
Our Team 

SurgMark consists of experienced shareholders with various areas of expertise.

 

Learn more about us:

Dr. rer. nat. Christine König (PhD) 
Business Management

… is an experienced biotech founder with many years of expertise in international top management consulting. 

 

Contact

Dr. med Peter Meier (M.D.)
Business Management

… is a serial entrepreneur and physician. 

He is enthusiastic about the development of innovations.

Dr. med Frank Schure (M.D.)

Clinical Research 

… is  over 30 years of experience in breast cancer treatment. In an award-winning partnership with Samsung, he is working on a tissue-sparing, ultrasound-assisted tumor resection.

Dr. med Rivelino Montenegro (PhD)
Production/Development

… is a chemist and repeatedly successful founder in the fields of medical technology, cosmetics and materials science.​

Dr. rer. nat. Thomas Freier (D.Sc.)

Quality Assurance/Development

… is a chemist, serial entrepreneur, and expert in medical devices and biomaterials.

Contact

Dr. Christine König

Dr. Peter Meier

Business and Medical Management

Telephone +49 177 4075795

Kunaustraße 7, 22393 Hamburg